Sarepta Therapeutics Inc (NASDAQ:SRPT) Share Price | RNS News, Quotes, & Charts

In brief

Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of both rare and infectious diseases.

In brief Deep dive Research Latest news Insight Interviews

Browse

Latest news

Under Armour slashes revenue outlook as fiscal first quarter sales decline

Oklo shares rise as revenue beat offsets wider Q2 loss

Nasdaq leads Wall Street higher as weak jobs data boosts Fed rate-cut hopes

Take-Two Q1 earnings beat expectations ahead of GTA VI launch

Twilio stock pops on better-than-expected Q2 report

Browse

Latest news

Spotlight

Under Armour slashes revenue outlook as fiscal first quarter sales decline

Oklo shares rise as revenue beat offsets wider Q2 loss

Nasdaq leads Wall Street higher as weak jobs data boosts Fed rate-cut hopes

Take-Two Q1 earnings beat expectations ahead of GTA VI launch

Twilio stock pops on better-than-expected Q2 report

Browse

Latest news

Horizon Gold sets sights on Gum Creek restart as drilling builds scale across historic WA gold camp

Phunware is a technology company powering personalized hospitality experiences with AI and mobile solutions

First Phoshpate will transform the Saguenay-Lac-Saint-Jean region into North America’s LFP Battery Valley

Fox Tungsten is advancing one of the world’s highest-grade tungsten deposits in central British Columbia

Fineqia's diverse portfolio shapes the landscape of tokenization, NFTs, and fintech

Browse

Latest news

Under Armour slashes revenue outlook as fiscal first quarter sales decline

Oklo shares rise as revenue beat offsets wider Q2 loss

Nasdaq leads Wall Street higher as weak jobs data boosts Fed rate-cut hopes

Take-Two Q1 earnings beat expectations ahead of GTA VI launch

Twilio stock pops on better-than-expected Q2 report

Sarepta Therapeutics Inc

In brief